The US Food and Drug Administration (FDA) has approved Supplemental New Drug Application (sNDA) for Eliquis (apixaban) to treat deep vein thrombosis (DVT), formation of a blood clot in a deep vein, and pulmonary embolism (PE), caused by blood clots that go from legs to the lungs. Pfizer Inc. and...read more
Achillion Pharmaceuticals Inc has achieved success in mid-stage trial of its experimental hepatitis C drug, ACH-3102. The medicine belongs to a new class of drugs that works by blocking the NS5A protein required by the virus to replicate.
The trial was carried out in 12 patients. The drug...read more
On Friday, the Food and Drug Administration gave green signal to Biogen Idec to market its new injectable drug meant for adults having multiple sclerosis.
The federal regulators have approved the drug called Plegridy as a longer lasting treatment for patients suffering from relapsing-...read more
Pfizer will have to shell out $35 million to settle the issue of illegally marketing an organ transplant drug for unapproved uses. The pharmaceutical company faced allegations from 42 states, including Mississippi, after its Wyeth Pharmaceuticals reportedly breached drug marketing policies....read more
A drug has been claimed to have great potential of cutting cholesterol. The drug has been developed by Sanofi SA and Regeneron Pharmaceuticals Inc. and it has yielded successful results in nine late-stage clinical trials.
Alirocumab is an injectible drug and belongs to a new class of...read more
Roche Holding AG, the Swiss health-care major, announced lower net profit after the earnings were weighed down by a strong Swiss franc and also incurring charges from one of its diagnostic units.
At the same time, the company reported that there has been growth in the company's overall...read more
A phase-III dengue vaccine efficacy study carried out in five countries in Asia by French drug-maker Sanofi has revealed promising results. On Friday, Sanofi Pasteur division announced about the details of the phase, which have been published in the journal Lancet.
The efficacy against...read more
Available drugs to treat atopic dermatitis, a chronic form of eczema, are not able to provide the desired effect. But soon, patients suffering from atopic dermatitis may be able to get relief as an experimental drug from Sanofi and Regeneron Pharmaceuticals Inc has shown reduction in skin...read more
- « first
The overall ‘asthma epidemic’ among children has...Read More
People in huge numbers gathered in the Mount Lofty...Read More
As New Year is approaching, people have already...Read More
Alzheimer’s disease, the commonest cause of...Read More
Cases of opioid abuse have been increasing and...Read More
In an announcement made on December 22, cable giant...Read More